Age-related changes in skin may contribute to melanoma metastases

by Johns Hopkins University School of MedicineAshani Weeraratna, Ph.D. Credit: Will Kirk/JHUAge-related changes that cause the skin to stiffen and become less elastic may also contribute to highe

Updated on: March 20,2024 15

Age-related changes in skin may contribute to melanoma metastases

by Johns Hopkins University School of MedicineAshani Weeraratna, Ph.D. Credit: Will Kirk/JHUAge-related changes that cause the skin to stiffen and become less elastic may also contribute to highe

Updated on:March 20,2024 15

Sex matters in how, when, and where melanomas develop

byElsevierFitted temporal trend of invasive cutaneous melanoma incidence (1982- 2018) for males vs. females from three populations (Queensland, US Whites, Scotland), by body site. Credit:J

Updated on: September 27,2024 0

Sex matters in how, when, and where melanomas develop

byElsevierFitted temporal trend of invasive cutaneous melanoma incidence (1982- 2018) for males vs. females from three populations (Queensland, US Whites, Scotland), by body site. Credit:J

Updated on:September 27,2024 0

Confirmatory testing underused for tinea capitis diagnosis

by Lori SolomonConfirmatory laboratory testing is only used in one in five cases of suspected tinea capitis (TC), according to a research letter published in the July issue of theJournal of the

Updated on: June 26,2024 6

Confirmatory testing underused for tinea capitis diagnosis

by Lori SolomonConfirmatory laboratory testing is only used in one in five cases of suspected tinea capitis (TC), according to a research letter published in the July issue of theJournal of the

Updated on:June 26,2024 6

Common skin cancer can signal increased risk of other cancers, researchers say

by Stanford University Medical CenterHuman skin structure. Credit: WikipediaPeople who develop abnormally frequent cases of a skin cancer known as basal cell carcinoma appear to be at significant

Updated on: June 06,2024 5

Common skin cancer can signal increased risk of other cancers, researchers say

by Stanford University Medical CenterHuman skin structure. Credit: WikipediaPeople who develop abnormally frequent cases of a skin cancer known as basal cell carcinoma appear to be at significant

Updated on:June 06,2024 5

FDA approves Leqselvi for severe alopecia

by Lori SolomonThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral select

Updated on: August 30,2024 0

FDA approves Leqselvi for severe alopecia

by Lori SolomonThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral select

Updated on:August 30,2024 0

Study finds link between eczema and peripheral vascular disease

byYale School of MedicineCredit: Unsplash/CC0 Public DomainPeople living with atopic dermatitis (AD, also known as eczema) are also at significantly higher risk for peripheral vascular disease (

Updated on: November 06,2024 0

Study finds link between eczema and peripheral vascular disease

byYale School of MedicineCredit: Unsplash/CC0 Public DomainPeople living with atopic dermatitis (AD, also known as eczema) are also at significantly higher risk for peripheral vascular disease (

Updated on:November 06,2024 0

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe

Updated on: September 25,2024 0

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe

Updated on:September 25,2024 0

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23

Updated on: November 13,2024 0

Long-term upadacitinib use feasible for adolescents with atopic dermatitis

by Lori SolomonLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23

Updated on:November 13,2024 0

10 Signs Your Body Is Begging for Vitamin D

Updated on: July 24,2024 0

10 Signs Your Body Is Begging for Vitamin D

Updated on:July 24,2024 0

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor

Updated on: June 25,2024 8

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor

Updated on:June 25,2024 8

FDA approves Nemluvio for moderate-to-severe atopic dermatitis

FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s

Updated on: January 06,2025 0

FDA approves Nemluvio for moderate-to-severe atopic dermatitis

FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s

Updated on:January 06,2025 0

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

Updated on: July 17,2024 0

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

Updated on:July 17,2024 0